Similar articles for PMID: 16080464

Year	Number of Results
1987	1
1988	1
1989	2
1993	2
1994	3
1995	1
1996	3
1997	1
1998	1
1999	3
2000	3
2001	2
2002	4
2003	8
2004	12
2005	17
2006	11
2007	10
2008	8
2009	11
2010	8
2011	6
2012	6
2013	8
2014	5
2015	2
2016	2
2018	6
2019	4
2020	7
2021	6
2022	4
2023	2
2024	0

1

Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability.

Campodonico F, Canepa G, Capponi G, Bozzo L, Maffezzini M. Campodonico F, et al. Anticancer Res. 2005 May-Jun;25(3c):2381-4. Anticancer Res. 2005. PMID: 16080464 Free article. Clinical Trial.

2

Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder.

Maffezzini M, Campodonico F, Canepa G, Capponi G, Fontana V. Maffezzini M, et al. Eur Urol. 2007 Apr;51(4):956-61. doi: 10.1016/j.eururo.2006.08.038. Epub 2006 Sep 20. Eur Urol. 2007. PMID: 17027141 Clinical Trial.

3

Intravesical gemcitabine in superficial bladder cancer: a phase II safety, efficacy and pharmacokinetic study.

Mattioli F, Curotto A, Manfredi V, Gosmar M, Garbero C, Ambruosi C, Carmignani G, Martelli A. Mattioli F, et al. Anticancer Res. 2005 May-Jun;25(3c):2493-6. Anticancer Res. 2005. PMID: 16080482 Free article. Clinical Trial.

4

Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.

Serretta V, Galuffo A, Pavone C, Allegro R, Pavone-MacAluso M. Serretta V, et al. Urology. 2005 Jan;65(1):65-9. doi: 10.1016/j.urology.2004.08.027. Urology. 2005. PMID: 15667865 Clinical Trial.

5

Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.

Campodonico F, Mattioli F, Manfredi V, Capponi G, Pasquini P, Martelli A, Maffezzini M. Campodonico F, et al. Anticancer Res. 2007 Mar-Apr;27(2):1179-83. Anticancer Res. 2007. PMID: 17465260 Free article. Clinical Trial.

6

Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer.

Palou J, Carcas A, Segarra J, Duque B, Salvador J, Garcia-Ribas I, Villavicencio H. Palou J, et al. J Urol. 2004 Aug;172(2):485-8. doi: 10.1097/01.ju.0000131770.14409.7f. J Urol. 2004. PMID: 15247710 Clinical Trial.

7

Randomized phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent Stage Ta urothelial cell carcinoma of the bladder.

Gårdmark T, Carringer M, Beckman E, Malmström PU; Members of the Intravesical Gemcitabine Study Group. Gårdmark T, et al. Urology. 2005 Sep;66(3):527-30. doi: 10.1016/j.urology.2005.03.084. Urology. 2005. PMID: 16140071 Clinical Trial.

8

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin.

Skinner EC, Goldman B, Sakr WA, Petrylak DP, Lenz HJ, Lee CT, Wilson SS, Benson M, Lerner SP, Tangen CM, Thompson IM. Skinner EC, et al. J Urol. 2013 Oct;190(4):1200-4. doi: 10.1016/j.juro.2013.04.031. Epub 2013 Apr 15. J Urol. 2013. PMID: 23597452 Free PMC article. Clinical Trial.

9

Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder: a phase I and pharmacokinetic study.

Laufer M, Ramalingam S, Schoenberg MP, Haisfield-Wolf ME, Zuhowski EG, Trueheart IN, Eisenberger MA, Nativ O, Egorin MJ. Laufer M, et al. J Clin Oncol. 2003 Feb 15;21(4):697-703. doi: 10.1200/JCO.2003.09.028. J Clin Oncol. 2003. PMID: 12586808 Clinical Trial.

10

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

Dalbagni G, Russo P, Sheinfeld J, Mazumdar M, Tong W, Rabbani F, Donat MS, Herr HW, Sogani P, dePalma D, Bajorin D. Dalbagni G, et al. J Clin Oncol. 2002 Aug 1;20(15):3193-8. doi: 10.1200/JCO.2002.02.066. J Clin Oncol. 2002. PMID: 12149290 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

149 results

Results by year